The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Neuroendocrine influences on cancer progression
Open accessAbstract
During the past decade, new studies have continued to shed light on the role of neuroendocrine regulation of downstream physiological and biological pathways relevant to cancer growth and progression. More specifically, our knowledge of the effects of the sympathetic nervous system (SNS) on cancer biology has been greatly expanded by new data demonstrating how the cellular immune response, inflammatory processes, tumor-associated angiogenesis, and tumor cell invasion and survival converge to promote tumor growth. This review will summarize these studies, while synthesizing clinical, cellular and molecular research that has continued to unearth the biological events mediating the interplay between SNS-related processes and cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and earlier cancer-related mortality [20–22]”
From A randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced cancer: study protocol. (2022) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 1×
“In this review, we will focus on chronic stress conditions that keep the body in a constant state of ‘‘overdrive’’, leading to deleterious downstream effects, deregulating the stress response and negatively affecting many organs systems (McEwen, 1998).”
BackgroundThe pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 2×
“Tumor cells must perform these steps while evading immune system surveillance, and the cells that fail in any of these tasks cannot metastasize (Fidler, 2003).”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 2×
“Besides catecholamines, glucocorticoids are also involved in the stress response and can control many normal physiological activities such as circadian rhythms, immune function and restoration of homeostasis (Glaser and Kiecolt-Glaser, 2005).”
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationThe influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981 · cited 6×
“Several studies have shown that the effect of stress hormones on cancer cell proliferation varies according to the specific hormone influences and the tumor type studied (as reviewed in Antoni et al., 2006).”
BackgroundInfluentialSelf-citationNeuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957 · cited 2×
“…disease have shown that tumor incidence and progression can be exacerbated by chronic stressors, mainly through the reduction of type 1 cytokines and T cell and natural killer cell activity resulting in impaired antigen presentation and higher numbers of regulatory T cells (Webster et al., 2002).”
BackgroundThe sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Self-citationMaximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2192 · Cited by 728 · cited 1×
“Various approaches have been used to model disease (Frese and Tuveson, 2007).”
MethodMolecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 713 · cited 2×
“ADRBs are the key components of the stress signaling pathway, and data now suggest that they also play a major role in protumoral signaling pathways (Cole and Sood, 2012).”
BackgroundSelf-citationEpac proteins: multi-purpose cAMP targets
Bos, J. L. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.10.002 · Cited by 532 · cited 1×
“Furthermore, it has been demonstrated that isoproterenol can promote ovarian cancer cell movement and adhesion via laminin-5 through an Epac1 dependent pathway (Bos, 2006).”
BackgroundBeta Blockers and Breast Cancer Mortality: A Population- Based Study
Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K., & Visvanathan, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5422 · Cited by 532 · cited 1×
“Furthermore, recent studies have reported that beta-blocker use can improve the outcomes of breast cancer patient (Barron et al., 2011; Melhem-Bertrandt et al., 2011; Powe and Entschladen, 2011).”
BackgroundImpact of Stress on Cancer Metastasis
Moreno‐Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 522 · cited 5×
“Furthermore, a rationale exists for the use of antidepressants, owing to their known antiinflammatory effects in the context of several types of cancer (Moreno-Smith et al., 2010).”
BackgroundInfluentialSelf-citationPsychologic intervention improves survival for breast cancer patients
Andersen, B. L., Yang, H., Farrar, W. B., Golden‐Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C., & Carson, W. E. (2008) · Cancer · doi:10.1002/cncr.23969 · Cited by 508 · cited 1×
“Although there are promising data relating psychosocial interventions to survival (Andersen et al., 2010, 2008), additional work is needed to understand the efficacy of such interventions and the physiological mechanisms mediating such results.”
BackgroundStress hormone-mediated invasion of ovarian cancer cells
Sood, A. K., Bhatty, R., Kamat, A. A., Landen, C. N., Han, L., Thaker, P. H., Li, Y., Gershenson, D. M., Lutgendorf, S., & Cole, S. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1698 · Cited by 491 · cited 2×
“Additionally, several in vivo and in vitro studies have shown that stress hormones can significantly increase the production of matrix metalloproteinase (MMP) 2 and 9 by ovarian cancer cells through ADRB-mediated pathways (Sood et al., 2006; Thaker et al., 2006).”
BackgroundSelf-citationMelhem‐Bertrandt, A., Chávez‐MacGregor, M., Lei, X. J., Brown, E. N., Lee, R. T., Meric‐Bernstam, F., Sood, A. K., Conzen, S. D., Hortobágyi, G. N., & Gonzalez-Angulo, A. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4441 · Cited by 471 · cited 1×
“Furthermore, recent studies have reported that beta-blocker use can improve the outcomes of breast cancer patient (Barron et al., 2011; Melhem-Bertrandt et al., 2011; Powe and Entschladen, 2011).”
BackgroundSelf-citationA stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
Hara, M. R., Kovacs, J. J., Whalen, E. J., Rajagopal, S., Strachan, R. T., Grant, W., Towers, A. J., Williams, B., Lam, C. M., Xiao, K., et al. (2011) · Nature · doi:10.1038/nature10368 · Cited by 420 · cited 1×
“…report indicating that chronic stress, through ADRB2-mediated signaling, leads to the accumulation of DNA damage in murine and human cell lines (Hara et al., 2011) suggest that new research strategies may shed light on the question of whether and/or under what conditions biobehavioral states,…”
BackgroundYang, E. V., Sood, A. K., Chen, M., Li, Y., Eubank, T. D., Marsh, C. B., Jewell, S., Flavahan, N. A., Morrison, C., Yeh, P.-E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2496 · Cited by 407 · cited 1×
“Experiments using human head and neck cancer cells have shown similar results, demonstrating that MMP levels were substantially elevated in response to NE treatment in these cell lines (Yang et al., 2006).”
ResultSelf-citationStress and Immune Responses After Surgical Treatment for Regional Breast Cancer
Andersen, B. L., Farrar, W. B., Golden‐Kreutz, D. M., Kutz, L. A., MacCallum, R. C., Courtney, M. E., & Glaser, R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.30 · Cited by 399 · cited 1×
“…patients that underwent surgery demonstrated immune alterations such as lowered T cell mediated secretion of TH1 versus TH2 cytokines, a poorer T-cell response to mitogen stimulation and reduced natural killer cell activity (Andersen et al., 1998; Blomberg et al., 2009; Thornton et al., 2007).”
BackgroundBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Bliss, V. S., Manseau, E. J., Dasgupta, P., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396 · cited 1×
“Alternatively, in vivo mouse and in vitro studies have shown that DA can abrogate VEGF-induced angiogenesis by reducing the downstream activity mediated by one of its receptors, VEGFR-2 (Basu et al., 2001).”
BackgroundCao, L., Liu, X., Lin, E.-J. D., Wang, C., Choi, E., Riban, V., Lin, B., & During, M. J. (2010) · Cell · doi:10.1016/j.cell.2010.05.029 · Cited by 378 · cited 1×
“…suggests that hypothalamic brain-derived neurotrophic factor can be selectively upregulated by the enriched environment, while proposing that genetic or environmental activation of this brain-derived neurotrophic factor-leptin axis may have therapeutic significance for cancer (Cao et al., 2010).”
BackgroundStressful Life Events and Risk of Breast Cancer in 10,808 Women: A Cohort Study
Lillberg, K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg002 · Cited by 360 · cited 2×
“…studies have reported that there is no relationship between stressful events (Duijts et al., 2003) or personality (Bleiker et al., 2008) and cancer incidence, while other reports seem to suggest that severe life stressors might induce cancer development (Lillberg et al., 2003; Price et al., 2001).”
BackgroundSocial support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Moreover, in ovarian cancer patients, distress at the time of surgery was associated with decreased natural killer cell activity in tumor infiltrating lymphocytes (TIL) and lower T cell secretion of TH1 and TH2 cytokines in peripheral blood mononuclear cells and TIL (Lutgendorf et al., 2005).”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 326
Self-citationTumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., & Albini, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4 · Cited by 316
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40802 · Cited by 283 · cited 2×
“We found that NE and Epi can protect ovarian cancer cells from anoikis by inducing the activation of focal adhesion kinase (FAK) through an ADRB/ PKA/Src dependent pathway (Sood et al., 2010).”
BackgroundSelf-citationRangarajan, S., Enserink, J. M., Kuiperij, H. B., de Rooij, J., Price, L., Schwede, F., & Bos, J. L. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209105 · Cited by 270 · cited 1×
“Another in vitro study reported that isoproterenol can stimulate cell adhesion to fibronectin in a cAMP-mediated Epac–Rap1 pathway (Rangarajan et al., 2003).”
BackgroundMerritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., Geest, K. D., Langley, R. R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn024 · Cited by 257
Self-citationComputational identification of gene–social environment interaction at the human IL6 locus
Cole, S. W., Arevalo, J. M. G., Takahashi, R., Sloan, E. K., Lutgendorf, S. K., Sood, A. K., Sheridan, J. F., & Seeman, T. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911515107 · Cited by 256 · cited 1×
“One study identified the genetic status at the interleukin 6 (IL6) locus as an important factor in ADRB activation of the transcriptional factor GATA1, potentially explaining how social adversity can affect health risk (Cole et al., 2010; Webster et al., 2002).”
BackgroundSelf-citationChronic Stress and Susceptibility to Skin Cancer
Saul, A. N., Oberyszyn, T. M., Daugherty, C., Kusewitt, D., Jones, S., Jewell, S., Malarkey, W. B., Lehman, A., Lemeshow, S., & Dhabhar, F. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji401 · Cited by 245 · cited 1×
“For example, mice exposed to ultraviolet radiation and undergoing chronic stress had an increased incidence of squamous cell carcinoma resulting from the reduction of type 1 cytokines and protective T-cell infiltrates (Saul et al., 2005).”
BackgroundSastry, K. S., Karpova, Y., Prokopovich, S., Smith, A. J., Essau, B., Gersappe, A., Carson, J. P., Weber, M. J., Register, T. C., Chen, Y. Q., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611370200 · Cited by 225 · cited 2×
“BAD is known to have pro-apoptotic functions in its unphosphorylated form, but once phosphorylated it releases Bcl-2 and B-cell lymphoma-extra large (Bcl-xL), thereby inhibiting the apoptotic process (Sastry et al., 2007).”
BackgroundCox, M., Deeble, P. D., Lakhani, S., & Parsons, S. J. (1999) · PubMed · Cited by 224
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer
Costanzo, E. S., Lutgendorf, S. K., Sood, A. K., Anderson, B., Sorosky, J., & Lubaroff, D. M. (2005) · Cancer · doi:10.1002/cncr.21147 · Cited by 217 · cited 1×
“Interestingly, ovarian cancer patients who experience distress and poor social support have elevated IL-6 levels, which have been associated with shorter survival in epidemiologic studies (Costanzo et al., 2005; Lutgendorf et al., 2008c).”
BackgroundSelf-citationTowards a mechanistic understanding of tumor invasion—lessons from theα 6 β 4integrin
Mercurio, A. M., & Rabinovitz, I. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0364 · Cited by 215 · cited 2×
“Recently, it was shown that cAMP, besides targeting PKA, can also signal through exchange protein activated by cAMP (EPAC), a widely expressed exchange factor for the small GTPases Ras-related protein (RAP) 1 and 2 (Mercurio and Rabinovitz, 2001).”
BackgroundSrc activation by β-adrenoreceptors is a key switch for tumour metastasis
Armaiz-Pena, G. N., Allen, J. K., Cruz, A., Stone, R. L., Nick, A. M., Lin, Y. G., Han, L. Y., Mangala, L. S., Villares, G. J., Vivas-Mejia, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms2413 · Cited by 212 · cited 1×
“Our analysis revealed that mortality was reduced by an average of 17% across all major cancer types if patients were treated with beta-blockers (Armaiz Pena et al., 2011).”
BackgroundSelf-citationInterleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
Lutgendorf, S. K., Weinrib, A., Penedo, F. J., Russell, D. W., DeGeest, K., Costanzo, E. S., Henderson, P. J., Sephton, S. E., Rohleder, N., Lucci, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1978 · Cited by 201
Self-citationGlucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr, I., Ucur, E., Herzer, K., Okouoyo, S., Ridder, R., Krammer, P. H., Doeberitz, M. V. K., & Debatin, K. (2003) · PubMed · Cited by 196
The association between stressful life events and breast cancer risk: A meta‐analysis
Duijts, S. F. A., Zeegers, M. P., & van den Borne, B. H. P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11504 · Cited by 194 · cited 3×
“Several studies have reported that there is no relationship between stressful events (Duijts et al., 2003) or personality (Bleiker et al., 2008) and cancer incidence, while other reports seem to suggest that severe life stressors might induce cancer development (Lillberg et al., 2003; Price et al.,…”
BackgroundStress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis
Shahzad, M. M. K., Arevalo, J. M. G., Armaiz-Peña, G. N., Lu, C., Stone, R. L., Moreno‐Smith, M., Nishimura, M., Lee, J., Jennings, N. B., Bottsford-Miller, J. N., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109579 · Cited by 189 · cited 2×
“Additionally, tumor-bearing mice undergoing chronic stress had increased levels of the pro-angiogenic factor, interleukin 8 (IL-8) that were mediated by FosB (Moreno-Smith et al., 2010; Shahzad et al., 2010).”
BackgroundSelf-citationFredriksson, J. M., Lindquist, J. M., Bronnikov, G. E., & Nedergaard, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13802 · Cited by 185 · cited 1×
“…human ovarian cancer cells in vitro that showed that norepinephrine and the beta agonist isoproterenol were both capable of inducing VEGF expression and that this effect was largely mediated by the ADRB/cAMP/Protein Kinase A (PKA) signaling axis (Fredriksson et al., 2000; Lutgendorf et al., 2003).”
BackgroundLara, H. E., Dissen, G. A., Leyton, V., Paredes, A., Fuenzalida, H., Fiedler, J. L., & Ojeda, S. R. (2000) · Endocrinology · doi:10.1210/endo.141.3.7395 · Cited by 182 · cited 1×
“Furthermore, rat ovarian catecholamine levels are augmented in response to increased sympathetic activity and this elevation has been associated with the appearance of precystic follicles (Lara et al., 2000).”
BackgroundDepression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer
Sephton, S. E., Dhabhar, F. S., Keuroghlian, A. S., Giese-Davis, J., McEwen, B. S., Ionan, A. C., & Spiegel, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.007 · Cited by 170 · cited 1×
“Advanced breast cancer patients diagnosed with clinical depression exhibit decreased cellular immunity (Sephton et al., 2009).”
BackgroundDepleted Dopamine in Gastric Cancer Tissues
Chakroborty, D., Sarkar, C., Mitra, R. B., Banerjee, S., Dasgupta, P., & Basu, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0059 · Cited by 163
Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada)
Perron, L., Bairati, I., Harel, F., & Meyer, F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036152.58271.5e · Cited by 160 · cited 1×
“For example, an epidemiological study found that patients who used beta-blockers had a reduced risk of developing prostate cancer, which suggests that ADRBs play a role in the development of prostate cancer (Perron et al., 2004).”
Vascular endothelial growth factor and social support in patients with ovarian carcinoma
Lutgendorf, S. K., Johnsen, E. L., Cooper, B., Anderson, B., Sorosky, J. I., Buller, R. E., & Sood, A. K. (2002) · Cancer · doi:10.1002/cncr.10739 · Cited by 160 · cited 2×
“Data now demonstrate a clear link between social support and elevated serum VEGF levels in ovarian cancer patients (Lutgendorf et al., 2002).”
BackgroundSelf-citationNilsson, M. B., Armaiz-Peña, G. N., Takahashi, R., Lin, Y. G., Trevino, J. G., Li, Y., Jennings, N., Arevalo, J. M. G., Lutgendorf, S. K., Gallick, G. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611539200 · Cited by 158 · cited 2×
“We have shown that NE can induce IL-6 production in ovarian cancer cells through a mechanism mediated by the Src kinase (Nilsson et al., 2007).”
BackgroundSelf-citationAndersen, B. L., Thornton, L. M., Shapiro, C. L., Farrar, W. B., Mundy, B. L., Yang, H.-C., & Carson, W. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0278 · Cited by 158 · cited 1×
“Although there are promising data relating psychosocial interventions to survival (Andersen et al., 2010, 2008), additional work is needed to understand the efficacy of such interventions and the physiological mechanisms mediating such results.”
BackgroundBiobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma
Lutgendorf, S. K., Lamkin, D. M., Jennings, N. B., Arevalo, J. M. G., Penedo, F., DeGeest, K., Langley, R. R., Lucci, J. A., Cole, S. W., Lubaroff, D. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0230 · Cited by 158 · cited 4×
“Interestingly, ovarian cancer patients who experience distress and poor social support have elevated IL-6 levels, which have been associated with shorter survival in epidemiologic studies (Costanzo et al., 2005; Lutgendorf et al., 2008c).”
BackgroundInfluentialSelf-citationNeuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer
Landen, C. N., Lin, Y. G., Armaiz Pena, G. N., Das, P. D., Arevalo, J. M., Kamat, A. A., Han, L. Y., Jennings, N. B., Spannuth, W. A., Thaker, P. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0858 · Cited by 144 · cited 2×
“Chronic stress can result in the activation of signal transducer and activator of transcription 3 (STAT-3), which increases tumor-associated angiogenesis in an orthotopic model of ovarian cancer (Landen et al., 2007).”
BackgroundSelf-citationNeuroendocrine modulation of cancer progression
Armaiz-Peña, G. N., Lutgendorf, S. K., Cole, S. W., & Sood, A. K. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.06.007 · Cited by 140
Self-citationMechanism of Surgical Stress Impairment of Human Perioperative Natural Killer Cell Cytotoxicity
Pollock, R. E. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410270082013 · Cited by 139 · cited 1×
“(Ben-Eliyahu et al., 1999; Pollock et al., 1991).”
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients
Lutgendorf, S. K., Lamkin, D. M., DeGeest, K., Anderson, B., Dao, M., McGinn, S., Zimmerman, B., Maiseri, H., Sood, A. K., & Lubaroff, D. M. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.012 · Cited by 126 · cited 4×
“Interestingly, ovarian cancer patients who experience distress and poor social support have elevated IL-6 levels, which have been associated with shorter survival in epidemiologic studies (Costanzo et al., 2005; Lutgendorf et al., 2008c).”
BackgroundInfluentialSelf-citationBasu, S., Sarkar, C., Chakroborty, D., Nagy, J. A., Mitra, R. B., Dasgupta, P., & Mukhopadhyay, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1600 · Cited by 123 · cited 2×
“Another interesting approach could be the use of dopamine analogues since dopamine replacement abrogates chronic stress-induced cancer growth (Basu et al., 2004; Moreno-Smith et al., 2011).”
BackgroundAguado, L. I., & Ojeda, S. R. (1984) · Endocrinology · doi:10.1210/endo-114-5-1845 · Cited by 117 · cited 1×
“For example, in the rat, it is well known that SNS-induced catecholamine release can play a role in the regulation of peripheral organs, such as the ovary, where stress hormones affect ovarian hormone production and menstrual cycle (Aguado and Ojeda, 1984; Ben-Jonathan et al., 1984).”
BackgroundDopamine Blocks Stress-Mediated Ovarian Carcinoma Growth
Moreno‐Smith, M., Lü, C., Shahzad, M. M. K., Armaiz-Peña, G. N., Allen, J. K., Stone, R. L., Mangala, L. S., Han, H. D., Kim, H. S., Farley, D. B., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2441 · Cited by 114 · cited 7×
“Another interesting approach could be the use of dopamine analogues since dopamine replacement abrogates chronic stress-induced cancer growth (Basu et al., 2004; Moreno-Smith et al., 2011).”
BackgroundInfluentialSelf-citationFlaxman, B. A., & Harper, R. A. (1975) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12598043 · Cited by 93 · cited 1×
“…on the effects of catecholamines on normal cell proliferation indicates that catecholamines are suppressors of cell proliferation, as it has been shown that stress hormones can delay wound healing, mainly by decreasing keratinocyte proliferation (Flaxman and Harper, 1975; Merritt et al., 2008).”
BackgroundExpression of human telomerase subunits in ovarian malignant, borderline and benign tumors
Kyo, S., Kanaya, T., Takakura, M., Tanaka, M., Yamashita, A., Inoue, H., & Inoue, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6 · Cited by 90
Cacioppo, J. T., Kiecolt‐Glaser, J. K., Malarkey, W. B., Laskowski, B. F., Rozlog, L. A., Poehlmann, K. M., Burleson, M. H., & Glaser, R. (2002) · Hormones and Behavior · doi:10.1006/hbeh.2002.1801 · Cited by 86 · cited 1×
“…element binding (CREB)mediated expression of viral oncogenes and growth factors that are known to promote tumor growth, and Epstein-Barr virus and high-risk variants of the human papilloma virus are similarly subject to activation by glucocorticoids (Cacioppo et al., 2002; Glaser et al., 1995).”
BackgroundUsing β-blockers to inhibit breast cancer progression
Powe, D. G., & Entschladen, F. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.123 · Cited by 82 · cited 1×
“Furthermore, recent studies have reported that beta-blocker use can improve the outcomes of breast cancer patient (Barron et al., 2011; Melhem-Bertrandt et al., 2011; Powe and Entschladen, 2011).”
BackgroundNeurohormones and Catecholamines as Functional Components of the Bone Marrow Microenvironment
Maestroni, G. J. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05370.x · Cited by 78 · cited 1×
“Catecholamine levels are also elevated in the murine bone marrow, as nerve endings and bone marrow cells possess the ability to secrete them into the bone marrow microenvironment (Maestroni, 2000).”
BackgroundBlomberg, B. B., Álvarez, J. P., Diaz, A., Romero, M. G., Lechner, S. C., Carver, C. S., Holley, H., & Antoni, M. H. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.05.016 · Cited by 72 · cited 1×
“…patients that underwent surgery demonstrated immune alterations such as lowered T cell mediated secretion of TH1 versus TH2 cytokines, a poorer T-cell response to mitogen stimulation and reduced natural killer cell activity (Andersen et al., 1998; Blomberg et al., 2009; Thornton et al., 2007).”
BackgroundHormonal Modulation of Epstein-Barr Virus Replication
Glaser, R., Kutz, L. A., MacCallum, R. C., & Malarkey, W. B. (2008) · Neuroendocrinology · doi:10.1159/000127025 · Cited by 71 · cited 1×
“…element binding (CREB)mediated expression of viral oncogenes and growth factors that are known to promote tumor growth, and Epstein-Barr virus and high-risk variants of the human papilloma virus are similarly subject to activation by glucocorticoids (Cacioppo et al., 2002; Glaser et al., 1995).”
BackgroundThornton, L. M., Andersen, B. L., Crespin, T. R., & Carson, W. E. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.06.007 · Cited by 71 · cited 1×
“…patients that underwent surgery demonstrated immune alterations such as lowered T cell mediated secretion of TH1 versus TH2 cytokines, a poorer T-cell response to mitogen stimulation and reduced natural killer cell activity (Andersen et al., 1998; Blomberg et al., 2009; Thornton et al., 2007).”
BackgroundPrice, M., Tennant, C. C., Smith, R. C., Butow, P. N., Kennedy, S. J., Kossoff, M. B., & Dunn, S. M. (2001) · PubMed · Cited by 71
Les traitements par β-bloquants pourraient-ils être associés à une diminution du risque de cancer ?
Algazi, M., Plu‐Bureau, G., Flahault, A., Dondon, M., & Lê, M. G. (2004) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(04)99022-0 · Cited by 68 · cited 1×
“A second study found that the use of beta-blockers by patients with cardiovascular disease significantly reduced their risk of cancer (Algazi et al., 2004).”
BackgroundNakane, T., Szentendrei, T., Stern, L., Virmani, M., Seely, J. E., & Kunos, G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.260 · Cited by 59
Chang, M., Brown, H. J., Collado-Hidalgo, A., Arevalo, J. M. G., Galić, Z., Symensma, T. L., Tanaka, L., Deng, H., Zack, J. A., Sun, R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13538-13547.2005 · Cited by 56 · cited 1×
“For example, human herpesvirus 8, which induces Kaposi’s sarcoma, possesses a cyclic adenosine monophosphate (cAMP) response element in the promoter of an important viral transcription factor (Chang et al., 2005).”
BackgroundSelf-citationPersonality Factors and Breast Cancer Risk: A 13-Year Follow-up
Bleiker, E. M. A., Hendriks, J. H. C. L., Otten, J. D. M., Verbeek, A. L. M., & van der Ploeg, H. M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm280 · Cited by 55 · cited 3×
“Several studies have reported that there is no relationship between stressful events (Duijts et al., 2003) or personality (Bleiker et al., 2008) and cancer incidence, while other reports seem to suggest that severe life stressors might induce cancer development (Lillberg et al., 2003; Price et al.,…”
BackgroundMarchetti, B., Spinola, P. G., Pelletier, G., & Labrie, F. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90102-b · Cited by 50 · cited 1×
“For example, in a rat model of breast cancer, ADRB activation was associated with increased tumor growth (Marchetti et al., 1991).”
BackgroundNorepinephrine in the Rat Ovary: Ontogeny andde NovoSynthesis*
Ben‐Jonathan, N., Arbogast, L. A., Rhoades, T. A., & Bahr, J. M. (1984) · Endocrinology · doi:10.1210/endo-115-4-1426 · Cited by 39 · cited 2×
“For example, in the rat, it is well known that SNS-induced catecholamine release can play a role in the regulation of peripheral organs, such as the ovary, where stress hormones affect ovarian hormone production and menstrual cycle (Aguado and Ojeda, 1984; Ben-Jonathan et al., 1984).”
BackgroundPifl, C., Zezula, J., Spittler, A., Kattinger, A., Reither, H., Caron, M. G., & Hornykiewicz, O. (2001) · The FASEB Journal · doi:10.1096/fj.00-0738fje · Cited by 25 · cited 2×
“It has been shown that NE can inhibit neuroblastoma cell growth, primarily in cells that express the DA transporter (Pifl et al., 2001).”
BackgroundTumor interactions with soluble factors and the nervous system
Voss, M. J., & Entschladen, F. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-21 · Cited by 25 · cited 1×
“Several in vitro and in vivo studies have demonstrated that NE can increase the migratory and metastatic potential of several types of cancers by inducing the activation of ADRB-mediated signaling cascades (Voss and Entschladen, 2010).”
BackgroundCatecholamine effects on human melanoma cells evoked by α1-adrenoceptors
Scarparo, A. C., Sumida, D. H., Patrão, M. T. C. C., Avellar, M. C. W., Visconti, M. A., & Castrucci, A. M. D. L. (2004) · Archives of Dermatological Research · doi:10.1007/s00403-004-0488-x · Cited by 23 · cited 1×
“Conversely, in human melanoma and neuroblastoma cells, catecholamines appear to inhibit tumor cell proliferation, a process that may be mediated by alpha adrenergic receptors (ADRA) (Bleiker et al., 2008; Lutgendorf et al., 2002; Pifl et al., 2001; Scarparo et al., 2004).”
Background
Cited by
Sorted by citations
Sympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576
Self-citationExploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
The impact of psychosocial stress and stress management on immune responses in patients with cancer
Antoni, M. H., & Dhabhar, F. S. (2019) · Cancer · doi:10.1002/cncr.31943 · Cited by 419
“The immune system is a crucial mediator through which stress affects the course of cancer,(2,6) although many immune-independent mechanisms also are critical mediators of cancer-related effects of stress.(7) In the current review, we focus on the effects of stress and stress management (SM) on immune function in relat…”
BackgroundDepression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M. H. J., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 399
“beta-adrenergic receptors on tumor and stromal cells [34].”
BackgroundInfluentialStress and cancer: mechanisms, significance and future directions
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348
Metadata
- Authors
- Armaiz-Pena, G. N., Cole, S. W., Lutgendorf, S. K., & Sood, A. K.
- Affiliations
- University of California, Los Angeles (US)
- University of Iowa (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Sood, Anil K.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 30
- Pages
- S19-S25
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC3467346
- OpenAlex
- W2113048638
- Cited by
- 145
- References
- 72
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 6 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 9 · 2019: 18 · 2018: 10 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 6 · 2013: 7
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 109298, R01CA110793, U54CA151668, CA 110793, CA-104825, R01CA109298, CA140933, R01CA104825, R01CA140933, P50CA083639, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Keywords
- neuroendocrine regulation, tumor progression, sympathetic nervous system, tumor growth, cell-mediated immunity, inflammation, tumor angiogenesis, tumor invasion, tumor cell survival
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Neurosecretory Systems, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review